Comparing a biosimilar follitropin alfa (Cinnal-fⓇ ) with Gonal-fⓇ in women undergoing ovarian stimulation: An RCT

Comparing a biosimilar follitropin alfa (Cinnal-fⓇ ) with Gonal-fⓇ in women undergoing ovarian stimulation: An RCT

Abstract Background: Advances in recombinant DNA technology led to the development of recombinant follitropin alfa. Recombinant human follicle-stimulating hormone products are used to stimulate follicular maturation. Objective: To compare the efficacy and safety of a biosimilar-candidate recombinant...

Full description

Bibliographic Details
Main Authors: Batool Hossein Rashidi, Khashayar Sayyari, Ramin Heshmat, Saeid Amanpour, Ensieh Shahrokh Tehraninejad, Masoumeh Masoumi, Farhang Rezaei
Format: Article
Language:English
Published: Shahid Sadoughi University of Medical Sciences 2021-11-01
Series:International Journal of Reproductive BioMedicine
Subjects:
follitropin alfa, biosimilar, efficacy, safety, intracytoplasmic sperm injection.
Online Access:https://doi.org/10.18502/ijrm.v19i11.9917

Internet

https://doi.org/10.18502/ijrm.v19i11.9917

Similar Items